Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-03 Option Award | 2024-08-06 8:00 pm | N/A 2034-08-02 | Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer | 52,000 | $0 | 52,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:10 pm | N/A 2034-04-30 | Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James CHIEF OPERATING OFFICER | 208,000 | $0 | 208,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 4:38 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James CHIEF OPERATING OFFICER | 77,500 | $0 | 77,500 (Direct) | View |
| 2023-08-16 Option Award | 2023-08-18 8:40 pm | N/A 2033-08-15 | Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James CHIEF OPERATING OFFICER | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-08-03 Option Award | 2023-08-07 4:12 pm | N/A 2033-08-02 | Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2023-08-07 4:09 pm | N/A 2031-03-28 | Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer | 0 | $0 | 398,172 (Direct) | View |